Clinical trials are growing across Africa as the immense potential of the continent starts to be realised. Sponsors and CROs ...

Takeda will take a one-time $900m (Y140bn) charge for the restructuring changes in FY 2024, with lower related expenses ...

Anixa Biosciences has expanded its partnership with Cleveland Clinic to develop additional vaccines for cancers.

The GHIT Fund announced an investment of Y1.64bn ($10.8m) in four new projects aimed at developing drugs to treat malaria and ...

Sobi gains approval for an indication extension from the European Commission for Aspaveli for adults with PNH who have ...

Rakovina will use the Deep Docking AI drug discovery platform that leverages deep learning platforms to identify novel drug ...

Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are ...

AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.

BioVersys and GSK have announced the expansion of their partnership to expedite the clinical development of alpibectir for ...

TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oestrogen receptor-positive (ER+) early breast ...

At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.